MMP Capital, a lender specializing in equipment financing, leasing and unsecured capital financing, originated more than $18 million in financing in April 2021, marking a 500% increase compared with April 2020 and a 125% increase compared with April 2019.

“Early quarter months are key indicators for future production since these months are traditionally slower and see about half of the normal production as our end-of-quarter months,” John-Paul Smolenski, CEO of MMP Capital, said. “The fact that we are seeing this level of demand so early in the quarter is a solid indicator that 2021 will be a strong year of business growth for MMP and its clients.”

Many small businesses have struggled during the COVID-19 pandemic due to forced shutdowns, limited customer capacities and an overall economic slowdown. As the United States starts to rebound, businesses have started to look to recoup lost revenue. MMP Capital, as a hybrid lender, can lend directly or utilize a syndication network to provide capital to small businesses.

“Small businesses appreciate our quick and efficient service as well as the strong relationship they build with their MMP team, who actually understands their business and business needs,” Smolenski said. “Every one of our employees, in every division, works tirelessly to become a true partner to our clients in helping them to achieve their goals.

“MMP Capital is a market leader in the aesthetic medical financing industry and has gained market share due to the company’s stellar reputation inside the industry by both key lending partners as well as key manufacturers who are looking to grow their revenue with MMP Capital’s streamlined approach to healthcare financing.”